Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Enk

Showing results (231-240 of 238) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 238 results.
International Journal of Cancer|May 29, 2015
Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanomaNikolaus B Wagner, Benjamin Weide, Maike Reith, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2020
Skin lesions of face and scalp - Classification by a market-approved convolutional neural network in comparison with 64 dermatologistsHolger Andreas Haenssle, Julia Katharina Winkler, Christine Fink, et al.
Nature Communications|December 5, 2025
Single cell mapping identifies a distinct platelet-phenotype in psoriatic type III inflammationKatharina S Kommoss, Sinduya Krishnarajah, Tabea Bieler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group TrialPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 13, 2018
Praxis der TeledermatologieMatthias Augustin, Johannes Wimmer, Tilo Biedermann, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2005
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)Ralf G Meyer, Cedrik M Britten, Ulrike Siepmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2019
Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> MutationsChristian Menzer, Alexander M Menzies, Matteo S Carlino, et al.
Journal of Cancer Research and Clinical Oncology|November 21, 2020
Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)Theresa Steeb, Anja Wessely, Mareike Alter, et al.
Pageof 24

Showing results (231-240 of 238) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 238 results.
International Journal of Cancer|May 29, 2015
Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanomaNikolaus B Wagner, Benjamin Weide, Maike Reith, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2020
Skin lesions of face and scalp - Classification by a market-approved convolutional neural network in comparison with 64 dermatologistsHolger Andreas Haenssle, Julia Katharina Winkler, Christine Fink, et al.
Nature Communications|December 5, 2025
Single cell mapping identifies a distinct platelet-phenotype in psoriatic type III inflammationKatharina S Kommoss, Sinduya Krishnarajah, Tabea Bieler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group TrialPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 13, 2018
Praxis der TeledermatologieMatthias Augustin, Johannes Wimmer, Tilo Biedermann, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2005
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)Ralf G Meyer, Cedrik M Britten, Ulrike Siepmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2019
Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> MutationsChristian Menzer, Alexander M Menzies, Matteo S Carlino, et al.
Journal of Cancer Research and Clinical Oncology|November 21, 2020
Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)Theresa Steeb, Anja Wessely, Mareike Alter, et al.
Pageof 24